scispace - formally typeset
G

Glenn M. Chertow

Researcher at Stanford University

Publications -  830
Citations -  94517

Glenn M. Chertow is an academic researcher from Stanford University. The author has contributed to research in topics: Kidney disease & Dialysis. The author has an hindex of 128, co-authored 764 publications receiving 82401 citations. Previous affiliations of Glenn M. Chertow include University of Groningen & Fresenius Medical Care.

Papers
More filters
Journal ArticleDOI

Trends and Outcomes Associated With Serum Albumin Concentration Among Incident Dialysis Patients in the United States

TL;DR: Although laboratory assays were not uniform within or across years, serum albumin declined over time, regardless of the reported laboratory lower limit of normal, and retained its potent association with mortality over time.
Journal ArticleDOI

Characteristics of uninsured Americans with chronic kidney disease.

TL;DR: Uninsured persons with non-dialysis dependent CKD are at higher risk for progression to ESRD than their insured counterparts but are less likely to receive recommended interventions to slow disease progression, which may result in missed opportunities toSlow disease progression and thereby reduce the public burden of E SRD.
Journal ArticleDOI

High prevalence of chronic kidney disease in a community survey of urban Bangladeshis: a cross-sectional study.

TL;DR: An alarmingly high prevalence of CKD—particularly CKD associated with insulin resistance—in middle-income, urban Bangladeshis is found, particularly in participants with stage three or more advanced CKD.
Journal Article

Hyperparathyroidism and dialysis vintage.

TL;DR: Dialysis vintage is a key determinant of the severity of secondary hyperparathyroidism and certain laboratory variables should be considered in the evaluation of therapies aimed at modifying the treated natural history of this disorder.
Journal ArticleDOI

High prevalence of type 2 diabetes among the urban middle class in Bangladesh

TL;DR: The prevalence of type-2 diabetes and metabolic syndrome among the middle class in Dhaka is alarmingly high and Screening services should be implemented while researchers focus on strategies to lessen the incidence and morbidity associated with these conditions.